Lung Cancer Foundation of America shared a post on LinkedIn:
“If you’ve been diagnosed with non-small cell lung cancer, one question worth asking is: What is my PD-L1 score?
In the latest Hope With Answers episode, patient advocate Colette Smith and Dr. Julie Brahmer break down what PD-L1 testing means, how it can help guide treatment decisions, and why understanding your biomarkers can help you have more informed conversations with your care team.
Amy C. Moore, Director of Patient Engagement and Advocacy at Summit Therapeutics, Inc., shared this post, adding:
“Learn more about PD-L1 and how it can inform your lung cancer treatment.”
Other articles featuring Amy C. Moore on OncoDaily.